Cargando…
Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box
BACKGROUND: Worldwide hundreds of millions of schistosomiasis patients rely on treatment with a single drug, praziquantel. Therapeutic limitations and the threat of praziquantel resistance underline the need to discover and develop next generation drugs. METHODOLOGY: We studied the antischistosomal...
Autores principales: | Ingram-Sieber, Katrin, Cowan, Noemi, Panic, Gordana, Vargas, Mireille, Mansour, Nuha R., Bickle, Quentin D., Wells, Timothy N. C., Spangenberg, Thomas, Keiser, Jennifer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886923/ https://www.ncbi.nlm.nih.gov/pubmed/24416463 http://dx.doi.org/10.1371/journal.pntd.0002610 |
Ejemplares similares
-
In vitro and in vivo antischistosomal activity of ferroquine derivatives
por: Keiser, Jennifer, et al.
Publicado: (2014) -
Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays
por: Panic, Gordana, et al.
Publicado: (2015) -
Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections
por: Keiser, Jennifer, et al.
Publicado: (2016) -
Development of an in vitro drug sensitivity assay based on newly excysted larvae of Echinostoma caproni
por: Panic, Gordana, et al.
Publicado: (2013) -
Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni
por: Panic, Gordana, et al.
Publicado: (2015)